Literature DB >> 17949987

SORL1 variants and risk of late-onset Alzheimer's disease.

Yonghong Li1, Charles Rowland, Joseph Catanese, John Morris, Simon Lovestone, Michael C O'Donovan, Alison Goate, Michael Owen, Julie Williams, Andrew Grupe.   

Abstract

A recent study reported significant association of late-onset Alzheimer's disease (LOAD) with multiple single nucleotide polymorphisms (SNPs) and haplotypes in SORL1, a neuronal sortilin-related receptor protein known to be involved in the trafficking and processing of amyloid precursor protein. Here we attempted to validate this finding in three large, well characterized case-control series. Approximately 2000 samples from the three series were individually genotyped for 12 SNPs, including the 10 reported significant SNPs and 2 that constitute the reported significant haplotypes. A total of 25 allelic and haplotypic association tests were performed. One SNP rs2070045 was marginally replicated in the three sample sets combined (nominal P=0.035); however, this result does not remain significant when accounting for multiple comparisons. Further validation in other sample sets will be required to assess the true effects of SORL1 variants in LOAD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949987      PMCID: PMC2323581          DOI: 10.1016/j.nbd.2007.09.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  13 in total

1.  High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

Authors:  S Germer; M J Holland; R Higuchi
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

3.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

Authors:  Olav M Andersen; Juliane Reiche; Vanessa Schmidt; Michael Gotthardt; Robert Spoelgen; Joachim Behlke; Christine A F von Arnim; Tilman Breiderhoff; Pernille Jansen; Xin Wu; Kelly R Bales; Roberto Cappai; Colin L Masters; Jørgen Gliemann; Elliott J Mufson; Bradley T Hyman; Steven M Paul; Anders Nykjaer; Thomas E Willnow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-07       Impact factor: 11.205

4.  Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family.

Authors:  Yonghong Li; Petra Nowotny; Peter Holmans; Scott Smemo; John S K Kauwe; Anthony L Hinrichs; Kristina Tacey; Lisa Doil; Ryan van Luchene; Veronica Garcia; Charles Rowland; Steve Schrodi; Diane Leong; Goran Gogic; Joanne Chan; Anibal Cravchik; David Ross; Kit Lau; Shirley Kwok; Sheng-Yung Chang; Joe Catanese; John Sninsky; Thomas J White; John Hardy; John Powell; Simon Lovestone; John C Morris; Leon Thal; Michael Owen; Julie Williams; Alison Goate; Andrew Grupe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-26       Impact factor: 11.205

5.  The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments.

Authors:  Katrin Offe; Sara E Dodson; James T Shoemaker; Jason J Fritz; Marla Gearing; Allan I Levey; James J Lah
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

6.  Role of genes and environments for explaining Alzheimer disease.

Authors:  Margaret Gatz; Chandra A Reynolds; Laura Fratiglioni; Boo Johansson; James A Mortimer; Stig Berg; Amy Fiske; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-02

7.  Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.

Authors:  Andrew Grupe; Richard Abraham; Yonghong Li; Charles Rowland; Paul Hollingworth; Angharad Morgan; Luke Jehu; Ricardo Segurado; David Stone; Eric Schadt; Maha Karnoub; Petra Nowotny; Kristina Tacey; Joseph Catanese; John Sninsky; Carol Brayne; David Rubinsztein; Michael Gill; Brian Lawlor; Simon Lovestone; Peter Holmans; Michael O'Donovan; John C Morris; Leon Thal; Alison Goate; Michael J Owen; Julie Williams
Journal:  Hum Mol Genet       Date:  2007-02-22       Impact factor: 6.150

8.  A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

Authors:  Andrew Grupe; Yonghong Li; Charles Rowland; Petra Nowotny; Anthony L Hinrichs; Scott Smemo; John S K Kauwe; Taylor J Maxwell; Sara Cherny; Lisa Doil; Kristina Tacey; Ryan van Luchene; Amanda Myers; Fabienne Wavrant-De Vrièze; Mona Kaleem; Paul Hollingworth; Luke Jehu; Catherine Foy; Nicola Archer; Gillian Hamilton; Peter Holmans; Chris M Morris; Joseph Catanese; John Sninsky; Thomas J White; John Powell; John Hardy; Michael O'Donovan; Simon Lovestone; Lesley Jones; John C Morris; Leon Thal; Michael Owen; Julie Williams; Alison Goate
Journal:  Am J Hum Genet       Date:  2005-11-15       Impact factor: 11.025

9.  Most published research findings are false-but a little replication goes a long way.

Authors:  Ramal Moonesinghe; Muin J Khoury; A Cecile J W Janssens
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  48 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.

Authors:  Liang-Hao Guo; Christine Westerteicher; Xin-Hui Wang; Martina Kratzer; Amalia Tsolakidou; Meizi Jiang; Timo Grimmer; Simon M Laws; Panagiotis Alexopoulos; Hideaki Bujo; Alexander Kurz; Robert Perneczky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09       Impact factor: 5.270

3.  The Alzheimer's associated 5' region of the SORL1 gene cis regulates SORL1 transcripts expression.

Authors:  Jeanette J McCarthy; Sunita Saith; Colton Linnertz; James R Burke; Christine M Hulette; Kathleen A Welsh-Bohmer; Ornit Chiba-Falek
Journal:  Neurobiol Aging       Date:  2010-12-23       Impact factor: 4.673

4.  No association of psychosis in Alzheimer disease with neurodegenerative pathway genes.

Authors:  Mary Ann A DeMichele-Sweet; Lambertus Klei; Bernie Devlin; Robert E Ferrell; Elise A Weamer; James E Emanuel; Oscar L Lopez; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2010-11-18       Impact factor: 4.673

Review 5.  Alzheimer's disease: advances in trafficking.

Authors:  Richard Mayeux; Peter St George Hyslop
Journal:  Lancet Neurol       Date:  2008-01       Impact factor: 44.182

Review 6.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

Review 7.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

8.  No association of SORL1 SNPs with Alzheimer's disease.

Authors:  Ryan L Minster; Steven T DeKosky; M Ilyas Kamboh
Journal:  Neurosci Lett       Date:  2008-05-27       Impact factor: 3.046

Review 9.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

10.  Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.

Authors:  Ziran Wang; Hongyan Lei; Mei Zheng; Yuxin Li; Yansen Cui; Fang Hao
Journal:  Mol Neurobiol       Date:  2015-11-27       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.